Logo image of SATS

ECHOSTAR CORP-A (SATS) Stock Fundamental Analysis

NASDAQ:SATS - Nasdaq - US2787681061 - Common Stock - Currency: USD

19.76  -1.19 (-5.68%)

After market: 19.82 +0.06 (+0.3%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SATS. SATS was compared to 96 industry peers in the Media industry. SATS has a bad profitability rating. Also its financial health evaluation is rather negative. SATS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SATS has reported negative net income.
SATS had a positive operating cash flow in the past year.
In multiple years SATS reported negative net income over the last 5 years.
SATS had a positive operating cash flow in each of the past 5 years.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.35%, SATS is in line with its industry, outperforming 55.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.07%, SATS is in line with its industry, outperforming 55.21% of the companies in the same industry.
Industry RankSector Rank
ROA -0.35%
ROE -1.07%
ROIC N/A
ROA(3y)-0.11%
ROA(5y)0.06%
ROE(3y)-1.37%
ROE(5y)-0.61%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

Looking at the Gross Margin, with a value of 25.23%, SATS is doing worse than 68.75% of the companies in the same industry.
SATS's Gross Margin has declined in the last couple of years.
SATS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.93%
GM growth 5Y-15.16%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SATS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SATS has more shares outstanding
SATS has a worse debt/assets ratio than last year.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

SATS has an Altman-Z score of 0.62. This is a bad value and indicates that SATS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.62, SATS is not doing good in the industry: 60.42% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.27 is on the high side and indicates that SATS has dependencies on debt financing.
SATS's Debt to Equity ratio of 1.27 is in line compared to the rest of the industry. SATS outperforms 45.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACC6.73%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

SATS has a Current Ratio of 1.26. This is a normal value and indicates that SATS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, SATS perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
SATS has a Quick Ratio of 1.19. This is a normal value and indicates that SATS is financially healthy and should not expect problems in meeting its short term obligations.
SATS's Quick ratio of 1.19 is in line compared to the rest of the industry. SATS outperforms 47.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.00% over the past year.
The Revenue for SATS has decreased by -23.85% in the past year. This is quite bad
Measured over the past years, SATS shows a very strong growth in Revenue. The Revenue has been growing by 53.02% on average per year.
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.5%
Revenue 1Y (TTM)-23.85%
Revenue growth 3Y99.75%
Revenue growth 5Y53.02%
Sales Q2Q%-3.61%

3.2 Future

SATS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.53% yearly.
SATS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.48% yearly.
EPS Next Y-936.63%
EPS Next 2Y-240.41%
EPS Next 3Y-134.87%
EPS Next 5Y18.53%
Revenue Next Year-2.77%
Revenue Next 2Y-1.9%
Revenue Next 3Y-1.19%
Revenue Next 5Y2.48%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SATS. In the last year negative earnings were reported.
Also next year SATS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

SATS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.9
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

SATS's earnings are expected to decrease with -134.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-240.41%
EPS Next 3Y-134.87%

More info and screens

0

5. Dividend

5.1 Amount

SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECHOSTAR CORP-A

NASDAQ:SATS (5/23/2025, 8:54:33 PM)

After market: 19.82 +0.06 (+0.3%)

19.76

-1.19 (-5.68%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners94.65%
Inst Owner Change0.39%
Ins Owners13.29%
Ins Owner Change0.64%
Market Cap5.68B
Analysts73.85
Price Target30.6 (54.86%)
Short Float %9.37%
Short Ratio4.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)169.49%
Min EPS beat(2)20.7%
Max EPS beat(2)318.29%
EPS beat(4)2
Avg EPS beat(4)28.11%
Min EPS beat(4)-197.05%
Max EPS beat(4)318.29%
EPS beat(8)4
Avg EPS beat(8)-62.75%
EPS beat(12)6
Avg EPS beat(12)-33.51%
EPS beat(16)9
Avg EPS beat(16)8.86%
Revenue beat(2)0
Avg Revenue beat(2)-1.54%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-2.04%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-1.1%
Revenue beat(8)1
Avg Revenue beat(8)-2.96%
Revenue beat(12)3
Avg Revenue beat(12)-2.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)0%
PT rev (3m)1.69%
EPS NQ rev (1m)-16.26%
EPS NQ rev (3m)-8.72%
EPS NY rev (1m)-19.73%
EPS NY rev (3m)-60.71%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF 5.62
P/B 0.28
P/tB 0.28
EV/EBITDA 15.9
EPS(TTM)-0.76
EYN/A
EPS(NY)-5.21
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)3.52
OCFY17.81%
SpS54.72
BVpS69.82
TBVpS69.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -1.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.23%
FCFM N/A
ROA(3y)-0.11%
ROA(5y)0.06%
ROE(3y)-1.37%
ROE(5y)-0.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.93%
GM growth 5Y-15.16%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 16.28
Cap/Depr 66.41%
Cap/Sales 8.19%
Interest Coverage N/A
Cash Conversion 64.79%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 0.62
F-Score4
WACC6.73%
ROIC/WACCN/A
Cap/Depr(3y)116.85%
Cap/Depr(5y)106.37%
Cap/Sales(3y)15.16%
Cap/Sales(5y)18.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.5%
EPS Next Y-936.63%
EPS Next 2Y-240.41%
EPS Next 3Y-134.87%
EPS Next 5Y18.53%
Revenue 1Y (TTM)-23.85%
Revenue growth 3Y99.75%
Revenue growth 5Y53.02%
Sales Q2Q%-3.61%
Revenue Next Year-2.77%
Revenue Next 2Y-1.9%
Revenue Next 3Y-1.19%
Revenue Next 5Y2.48%
EBIT growth 1Y-186.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year696.8%
EBIT Next 3Y109.06%
EBIT Next 5Y72.49%
FCF growth 1Y-258.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.78%
OCF growth 3Y25.6%
OCF growth 5Y13.8%